A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck Cancer
Conditions: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Interventions: Biological: Amivantamab; Biological: Pembrolizumab; Drug: Paclitaxel Sponsors: Janssen Research& Development, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Conditions: Metastatic Breast Cancer Interventions: Drug: ESG401; Drug: Eribulin, capecitabine, gemcitabine or vinorelbine (Treatment of Physician ' s Choice) Sponsors: Shanghai Escugen Biotechnology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies
Conditions: Lymphodepleting Chemotherapy; Myeloid Malignancies Interventions: Drug: Cyclophosphamide; Drug: Fludarabine phosphate; Drug: Decitabine Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
A RCT of Supraclavicular Lymph Node Dissection vs. No-dissection in Supraclavicular Lymph Node Metastatic Breast Cancer
Conditions: Breast Cancer; Ipsilateral Supraclavicular Lymph Node Metastasis Interventions: Procedure: Supraclavicular lymph node dissection combined with radiotherapy; Radiation: radiotherapy Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) MRI as a Response Monitoring Tool to Neoadjuvant Abiraterone
Conditions: High Risk Prostate Carcinoma; Prostate Cancer Interventions: Drug: Abiraterone acetate; Drug: Prednisone; Drug: Hyperpolarized [1-13C] pyruvate (HP 13C); Procedure: Magnetic Resonance Imaging (MRI); Procedure: Non-investigational radical prostatectomy (RP); Procedure: Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) PET/Computerized tomography (CT) Sponsors: Ivan de Kouchkovsky, MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients
Conditions: Gastric Cancer Interventions: Drug: Lenvatinib and Sintilimab Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2
Conditions: Breast Cancer; Lung Cancer; Genito-Urinary Cancer; Colorectal Cancer; Gastric Cancer; Pancreatic Cancer; Liver Cancer; Head and Neck Cancer; Melanoma Interventions: Behavioral: Hello for Cancer game; Other: Table Topics game Sponsors: Milton S. Hershey Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC
Conditions: Metastatic Castration-resistant Prostate Cancer Interventions: Drug: 177Lu-NYM032 injection Sponsors: Norroy Bioscience Co., LTD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China
Conditions: Gastric Cancer Interventions: Other: Financial Incentives; Other: Motivational Intervention; Other: Mixed Intervention Sponsors: Peking University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Skin Cancer and Hyperthermia and Radiotherapy
Conditions: Basal Cell Carcinoma; Squamous Cell Carcinoma Skin; Non-melanoma Skin Cancer Interventions: Combination Product: Water-filtered infrared-A-hyperthermia (wIRA) hyperthermia combined; Radiation: Radiotherapy (RT) Sponsors: Kantonsspital Winterthur KSW; Luzerner Kantonsspital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Osimertinib as Neoadjuvant Therapy in Patients With Resectable Stage II-IIIB EGFR-mutated Lung Squamous Cell Carcinoma
Conditions: Lung Cancer; Carcinoma, Squamous Cell Interventions: Drug: Osimertinib Sponsors: The First Affiliated Hospital of Guangzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
Conditions: Metastatic Tumor; Advanced Solid Tumor; Renal Cell Carcinoma; Ovarian Cancer; Cervix Cancer; Head and Neck Squamous Cell Carcinoma; Nasopharyngeal Carcinoma Interventions: Drug: CHT101 Sponsors: Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources
Conditions: Stage II Lung Cancer; Stage III Lung Cancer; Stage IV Lung Cancer Interventions: Other: Support for Caregiver - Generic List; Other: Support for Caregiver - Personalized List; Other: Internet-Based Intervention - CONNECT; Behavioral: Patient Navigation Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
Conditions: Glioblastoma; Head and Neck Cancer Interventions: Other: Psychological Tests ' administration Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer
Conditions: Efficacy and Safety Interventions: Drug: HR070803; Drug: Oxaliplatin; Drug: Tegafur; Drug: Folinic acid; Drug: 5-Fluorouracil Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
